Role of HbA1c as a Marker of Dyslipidemia in Patients with Type 2 Diabetes Mellitus Visiting Tertiary Health Care Center
Keywords:Type 2 Diabetes, Dyslipidemia, HbA1c
Introduction: Diabetic patients with accompanied (but often unnoticed) dyslipidemia are soft targets of cardiovascular deaths. Glycated hemoglobin (HbA1c) is a routinely used marker for long-term glycemic control. This investigation is an attempt to evaluate the diagnostic value of HbA1c in predicting diabetic dyslipidemia.
Methods: This was a cross-sectional study where the sera were analyzed for HbA1c, fasting blood glucose (FBG), total cholesterol, triglycerides, highdensity lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol. SPSS version 23.0 was used to analyze the data.
Results: The levels of HbA1c did not differ significantly between males and females whereas male patients had significantly higher fasting blood glucose than females. There was a highly significant correlation between HbA1c and FBG. Both HbA1c and fasting blood glucose exhibited direct correlations with cholesterol, TG and LDL and inverse correlation with HDL; the magnitude of significance for all these lipid parameters being greater with HbA1c than fasting blood glucose.
Conclusions: HbA1c can provide valuable information about the circulating lipids beside its primary role in monitoring long term glycemic control.
How to Cite
Copyright (c) 2023 Medical Journal of Shree Birendra Hospital
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.